Page 203 - Abstract Book KONIKA 18
P. 203

Endocrinology

                                              P-ENDO-053
                Correlation Control Metabolic and Thyroid Stimulating Hormone Levels
                   in Children with Type 1 Diabetes Mellitus in Dr. M. Djamil Hospital

                                       Ivanny Khosasih, Eka Agustia Rini
             Department of Pediatrics, Endocrinology Division, Faculty of Medicine, Universitas Andalas/Dr. M. Djamil Hospital,
                                        Padang, West Sumatera, Indonesia

                                               Abstract
            Background Thyroid disease (TD) and type 1 diabetes mellitus (T1DM) are both prevalent endocrinopathies.
            Asymptomatic TD is prevalent among diabetic patients, particularly T1DM patients. Association between
            control metabolic and thyroid stimulating hormone (TSH) levels remains inconclusive.  Objective To
            describe thyroid stimulating hormone levels in T1DM and the correlation with control metabolic. Methods
            We conducted a cross sectional study from 44 patient T1DM since Januari - Desember 2020 in the Pediatric
            Endocrine Outpatient at M. Djamil Hospital. The correlation of thyroid stimulating hormone levels (TSH)
            with metabolic controlled was analyzed by Pearson correlation analysis. Results The prevalence of T1DM
            was twenty six (54.2%) in females and eightteen (45,8%) in males. The overall mean age was 14,15 years
            and mean duration of diabetic was 2.5 years. Eight (18,18%) were undernourished, two (4,54%) were obese
            and thiry four (77.28%) were well nourished. Their mean TSH concentration was 2,3552 mIU/L, no patient
            with hypothyroid, thirty four (77.3%) had poor metabolic control. No patient with hypothyroidism (mean
            FT4 15.1 pmol/L, with range 11.9-17 4 pmol/L). Pearson’s correlation test revealed no significant association
            between metabolic control and TSH. (P= 0,109). Conclusion There is no significant association between
            metabolic control and TSH levels in children with T1DM.
                                  Keywords: type 1 diabetes mellitus; children; thyroid


                                              P-ENDO-054
                      Congenital Hyperinsulinism and Global Developmental Delay
                                 in A 10-month-old Boy: A Case Report
                           Chintami Putri Rejekiya, Irfan Agus Salim, Harjoedi Adji Tjahyono
                 Departement of Child Health, Faculty of Medicine Universitas Brawijaya/Saiful Anwar General Hospital,
                                         Malang, East Java, Indonesia
                                               Abstract
            Background Hyperinsulinaemic hypoglycemia (HH) is an important cause of recurrent and severe
            hypoglycemia during infancy and childhood. In children, congenital hyperinsulinism (CHI) is the most
            common cause of HH and it typically presents in early infancy. Case We presented a case of congenital
            hyperinsulinism and global developmental delay in A 10 months old boy The diagnosis was established
            by a history of lethargy and seizure 3 days before admission. The random blood glucose result on the day
            of admission was low. Laboratory results confirm hyperinsulinaemic   hypoglycemia, because the pH
            results are normal, ketones are normal, lactate are normal,and growth hormone normal. From radiological
            work-ups in MRI of the pancreas showed normal size, there is no visible pathological signal. He was
            treated with Intravenous glucose infusion, intravenous hydrocortisone therapy, subcutan Octreotide, and
            Oral nifedipine. The patient also received physiotherapy for treatment of global developmental delay.
            Discussion The American Academy of Pediatrics (AAP) and the Pediatric Endocrine Society (PES) have
            both accepted that plasma glucose values drop down to 30 mg/dL (1.67 mmol/L) in the first 2 hours of life
            and subsequently rise to a value of at least 45 mg/dL (2.5 mmol/L) before stabilizing around 12-24 hours.
            Hyperinsulinaemic hypoglycemia (HH), refers to a clinically, genetically and morphologically heterogeneous
            group of disorders associated with dysregulated insulin secretion. It is the most common cause of persistent
            hypoketotic hypoglycemia in neonates and infants and is associated with a significant risk of permanent
            brain damage. The goal of emergency treatment is to achieve normoglycemia immediately, keep plasma
            glucose levels at a safe range (>3.5 mmol/L/65 mg/dL) while the etiological investigations for differential
            diagnosis and long-term treatment planning are in progress. Conclussion A prompt diagnosis and immediate
            management of HH is essential to avoid complications. A thorough clinical examination and utility of
            laboratory examination from the critical sample can be used to diagnosed the etiology of HH.
                           Keywords: hypoglycemia; hyperinsulinaemic; global developmental delay


                                           KONIKA XVIII Abstract Book                                                                     155
   198   199   200   201   202   203   204   205   206   207   208